Serum Phosphorus and Pill Burden Among Hemodialysis Patients Prescribed Sucroferric Oxyhydroxide: One-Year Follow-Up on a Contemporary Cohort
Jessica B Kendrick,1 Meijiao Zhou,2 Linda H Ficociello,2 Vidhya Parameswaran,2 Claudy Mullon,2 Michael S Anger,2,3 Daniel W Coyne4 1University of Colorado Anschutz Medical Campus, Aurora, CO, USA; 2Fresenius Medical Care Global Medical Office, Waltham, MA, USA; 3Unversity of Colorado School of Medic...
Main Authors: | Kendrick JB, Zhou M, Ficociello LH, Parameswaran V, Mullon C, Anger MS, Coyne DW |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2022-04-01
|
Series: | International Journal of Nephrology and Renovascular Disease |
Subjects: | |
Online Access: | https://www.dovepress.com/serum-phosphorus-and-pill-burden-among-hemodialysis-patients-prescribe-peer-reviewed-fulltext-article-IJNRD |
Similar Items
-
Changes in serum albumin and other nutritional markers when using sucroferric oxyhydroxide as phosphate binder among hemodialysis patients: a historical cohort study
by: Kamyar Kalantar-Zadeh, et al.
Published: (2019-10-01) -
Phosphate binder pill burden, adherence, and serum phosphorus control among hemodialysis patients converting to sucroferric oxyhydroxide
by: Gray K, et al.
Published: (2019-01-01) -
Efficacy and Safety of Sucroferric Oxyhydroxide and Calcium Carbonate in Hemodialysis Patients
by: Fumihiko Koiwa, et al.
Published: (2018-01-01) -
Comparative analysis of the phosphate-binding effects of sucroferric oxyhydroxide, ferric citrate, and lanthanum carbonate
by: Takeo Ishii, et al.
Published: (2017-09-01) -
The real-world effectiveness of sucroferric oxyhydroxide in European hemodialysis patients: a 1-year retrospective database analysis
by: Rosa Ramos, et al.
Published: (2020-12-01)